NCT02706353 2025-11-21APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic MelanomaM.D. Anderson Cancer CenterPhase 1/2 Terminated34 enrolled 18 charts
NCT03502330 2024-07-03APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell CarcinomaYale UniversityPhase 1 Completed42 enrolled 17 charts